A Randomized Phase III Trial Comparing FEC-Chemotherapy vs. EC-Doc-Chemotherapy in Patients With Primary Breast Cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cyclophosphamide; Docetaxel; Epirubicin; Fluorouracil
- Indications Advanced breast cancer; Breast cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms ADEBAR
- 30 May 2013 Biomarkers information updated
- 05 Jun 2012 Results presented at the 48th Annual Meeting of the American Society of Clinical Oncology.
- 07 Mar 2012 Actual end date (1 Feb 2012) added as reported by ClinicalTrials.gov.